On February 18, 2025, Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback